Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day

Background: In advanced bladder cancer (BCa), platinum-based chemotherapy represents the first-choice treatment. In the last ten years, immune checkpoint inhibitors (ICIs) have changed the therapeutic landscape of many solid tumors. Our review aims to summarize the main findings regarding the clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Maiorano, Brigida Anna, De Giorgi, Ugo, Ciardiello, Davide, Schinzari, Giovanni, Cisternino, Antonio, Tortora, Giampaolo, Maiello, Evaristo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962271/
https://www.ncbi.nlm.nih.gov/pubmed/35203620
http://dx.doi.org/10.3390/biomedicines10020411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962271/
https://www.ncbi.nlm.nih.gov/pubmed/35203620
http://dx.doi.org/10.3390/biomedicines10020411

Ejemplares similares